Return On Assets in % of Regen BioPharma Inc from Q4 2014 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regen BioPharma Inc quarterly/annual Return On Assets history and change rate from Q4 2014 to Q2 2025.
  • Regen BioPharma Inc Return On Assets for the quarter ending 30 Jun 2025 was -538 %, a 53.4% decline year-over-year.
  • Regen BioPharma Inc annual Return On Assets for 2024 was -423 %, a 234% decline from 2023.
  • Regen BioPharma Inc annual Return On Assets for 2023 was 317 %, a 15.2% decline from 2022.
  • Regen BioPharma Inc annual Return On Assets for 2022 was 374 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Regen BioPharma Inc Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -538 -187 -53.4% 01 Apr 2025 30 Jun 2025
Q1 2025 -537 -243 -82.4% 01 Jan 2025 31 Mar 2025
Q4 2024 -623 -416 -201% 01 Oct 2024 31 Dec 2024
Q3 2024 -420 -737 -232% 01 Jul 2024 30 Sep 2024
Q2 2024 -351 -688 -204% 01 Apr 2024 30 Jun 2024
Q1 2024 -295 -13.5K -102% 01 Jan 2024 31 Mar 2024
Q4 2023 -207 -457 -183% 01 Oct 2023 31 Dec 2023
Q3 2023 317 -56.9 -15.2% 01 Jul 2023 30 Sep 2023
Q2 2023 337 +198 +142% 01 Apr 2023 30 Jun 2023
Q1 2023 13.2K +20.5K 01 Jan 2023 31 Mar 2023
Q4 2022 250 +900 01 Oct 2022 31 Dec 2022
Q3 2022 374 +1.28K 01 Jul 2022 30 Sep 2022
Q2 2022 139 +1.03K 01 Apr 2022 30 Jun 2022
Q1 2022 -7.31K -12.1K -253% 01 Jan 2022 31 Mar 2022
Q4 2021 -650 -2.37K -138% 01 Oct 2021 31 Dec 2021
Q3 2021 -910 -4.76K -124% 01 Jul 2021 30 Sep 2021
Q2 2021 -886 -5.82K -118% 01 Apr 2021 30 Jun 2021
Q1 2021 4.76K +8.8K 01 Jan 2021 31 Mar 2021
Q4 2020 1.72K +1.43K +498% 01 Oct 2020 31 Dec 2020
Q3 2020 3.85K +6.23K 01 Jul 2020 30 Sep 2020
Q2 2020 4.93K +8.71K 01 Apr 2020 30 Jun 2020
Q1 2020 -4.04K -3.68K -1030% 01 Jan 2020 31 Mar 2020
Q4 2019 288 +683 01 Oct 2019 31 Dec 2019
Q3 2019 -2.39K -1.68K -238% 01 Jul 2019 30 Sep 2019
Q2 2019 -3.77K -3.38K -845% 01 Apr 2019 30 Jun 2019
Q1 2019 -357 +263 +42.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -395 +272 +40.8% 01 Oct 2018 31 Dec 2018
Q3 2018 -705 +21.2 +2.92% 01 Jul 2018 30 Sep 2018
Q2 2018 -399 +976 +71% 01 Apr 2018 30 Jun 2018
Q1 2018 -620 +1.22K +66.3% 01 Jan 2018 31 Mar 2018
Q4 2017 -667 +1.62K +70.9% 01 Oct 2017 31 Dec 2017
Q3 2017 -726 +2.14K +74.7% 01 Jul 2017 30 Sep 2017
Q2 2017 -1.38K +1.03K +42.8% 01 Apr 2017 30 Jun 2017
Q1 2017 -1.84K +288 +13.5% 01 Jan 2017 31 Mar 2017
Q4 2016 -2.29K +1.65K +41.9% 01 Oct 2016 31 Dec 2016
Q3 2016 -2.87K +1.41K +32.9% 01 Jul 2016 30 Sep 2016
Q2 2016 -2.41K +2.74K +53.3% 01 Apr 2016 30 Jun 2016
Q1 2016 -2.13K +3.55K +62.5% 01 Jan 2016 31 Mar 2016
Q4 2015 -3.94K -2.72K -221% 01 Oct 2015 31 Dec 2015
Q3 2015 -4.27K 01 Jul 2015 30 Sep 2015
Q2 2015 -5.15K 01 Apr 2015 30 Jun 2015
Q1 2015 -5.68K 01 Jan 2015 31 Mar 2015
Q4 2014 -1.23K 01 Oct 2014 31 Dec 2014

Regen BioPharma Inc Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -423 -740 -234% 01 Oct 2023 30 Sep 2024
2023 317 -56.9 -15.2% 01 Oct 2022 30 Sep 2023
2022 374 +1.28K 01 Oct 2021 30 Sep 2022
2021 -910 -4.76K -124% 01 Oct 2020 30 Sep 2021
2020 3.85K +6.23K 01 Oct 2019 30 Sep 2020
2019 -2.39K -1.68K -238% 01 Oct 2018 30 Sep 2019
2018 -705 +21.2 +2.92% 01 Oct 2017 30 Sep 2018
2017 -726 +2.14K +74.7% 01 Oct 2016 30 Sep 2017
2016 -2.87K +1.41K +32.9% 01 Oct 2015 30 Sep 2016
2015 -4.27K 01 Oct 2014 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.